-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

1844 Caspase 8 Deletion Causes Infection/Inflammation-Induced MDS-like Bone Marrow Failure in Mice

Program: Oral and Poster Abstracts
Session: 636. Myelodysplastic Syndromes – Basic and Translational: Poster I
Saturday, December 9, 2023, 5:30 PM-7:30 PM

Kanak Joshi, MS1*, Shanhui Liu, PhD2*, Lei Zhang, PhD3*, Ryan Michael Mack, BS4, Austin Runde, MS5*, Patrick Hagen, MD, MPH6*, Kevin Barton, MD7, Peter Breslin, PhD8*, Ameet R. Kini, MD, PhD9 and Jiwang Zhang, MD, PhD1*

1Department of Cancer Biology, Loyola University Medical Center, Maywood, IL
2Second Hospital of Lanzhou University, Lanzhou, China
3Soochow University, Suzhou, China
4Department of Cancer Biology, Loyola University Chicago, Oak Park, IL
5Loyola University Medical Center, Maywood
6Division of Hematology and Oncology, Loyola University Medical Center, Maywood, IL
7Department of Medicine, Loyola University-Chicago, Maywood, IL
8Department of Cancer, Loyola University Medical Center, Maywood, IL
9Loyola Univ. Medical Ctr., Maywood, IL

Myelodysplastic syndromes (MDS) are a heterogeneous group of pre-leukemic hematopoietic disorders characterized by persistent cytopenia in peripheral blood (PB) and normo- or hypercellular and morphologic dysplasia in bone marrow (BM) due to ineffective hematopoiesis, as well as resulting in an elevated risk for leukemic transformation. Bacterial or viral infections increase the severity of MDS patients’ symptoms. An inflammatory BM micro-environment and programmed cell death of hematopoietic stem/progenitor cells (HSPCs) have been thought to be the major causes leading to ineffective hematopoiesis. Three types of programed cell death, apoptosis, necroptosis and pyroptosis, were observed in BM tissues of MDS patients, suggesting PANoptosis might play a critical role in the pathogenesis of MDS. Caspase 8 (Casp8) is a master regulator of PANoptosis. Casp8 is downregulated in HSPCs from patients with MDS, and is associated with increased Ripk1 protein, which is another master regulator of PANoptosis. To study the role of PANoptosis in normal hematopoiesis and the pathogenesis of MDS, we generated Mx1-Cre and Rosa-ERT2Cre–mediated inducible Casp8 knockout mice (Casp8-/-). Mx1-CreCasp8-/- mice died of BM failure within 10 days of three polyI:C injections (administered every other day) due to the massive depletion of HSPCs. This could be completely rescued by Ripk3 deletion, suggesting that HSPCs were eliminated by necroptosis. Rosa-ERT2Cre-Casp8-/- mice are completely normal without any significant changes in BM hematopoiesis after induction by five doses of tamoxifen (TAM) when maintained in specific pathogen-free facilities. However, such mice developed a spontaneous BM failure phenotype when maintained in quarantine facilities. This BM failure can be attenuated by antibiotic treatment, suggesting that the phenotype is infection-induced. In addition, low dose polyI:C injections or treatment with LPS also induces BM failure in Rosa-ERT2Cre - Casp8-/- mice living in germ-free conditions. Detailed analysis suggested that Casp8-/- HSPCs are hypersensitive to polyI:C, LPS, TNFα and IFNα/γ-induced cell death. Most importantly, all these phenotypic and functional abnormalities observed in Rosa-ERT2Cre-Casp8-/- mice can be completely prevented by Ripk3 deletion. In addition, serial transplantation study demonstrated that Casp8-/- HSCs have impaired self-renewal capacity. Interestingly, the self-renewal of Casp8-/-Ripk3-/- HSCs is significantly enhanced compared to Wild-type HSCs. Our study suggests an essential role for a balance in Casp8 and Ripk3 activities in the regulation of normal hematopoiesis and the self-renewal of HSCs, the disruption of which might induce inflammation and BM failure, resulting in MDS-like disease.

Disclosures: No relevant conflicts of interest to declare.

Previous Abstract | Next Abstract >>
*signifies non-member of ASH